Analysen zu AstraZeneca PLC
| 09.09.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 09.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 05.09.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 03.09.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 15.08.24 | AstraZeneca Sell | UBS AG | |
| 15.08.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 13.08.24 | AstraZeneca Sell | UBS AG | |
| 05.08.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.07.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 29.07.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 26.07.24 | AstraZeneca Halten | DZ BANK | |
| 26.07.24 | AstraZeneca Sell | UBS AG | |
| 25.07.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 23.07.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 10.07.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 10.07.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 04.07.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 03.07.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.07.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 26.06.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 25.06.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 24.06.24 | AstraZeneca Overweight | Barclays Capital | |
| 18.06.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 10.06.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 07.06.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 05.06.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 05.06.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 04.06.24 | AstraZeneca Sell | UBS AG | |
| 03.06.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 30.05.24 | AstraZeneca Buy | Goldman Sachs Group Inc. | |
| 28.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 22.05.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 22.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 21.05.24 | AstraZeneca Sell | UBS AG | |
| 20.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 15.05.24 | AstraZeneca Sell | UBS AG | |
| 14.05.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.05.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 07.05.24 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.04.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 29.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 26.04.24 | AstraZeneca Halten | DZ BANK | |
| 26.04.24 | AstraZeneca Sell | UBS AG | |
| 26.04.24 | AstraZeneca Hold | Deutsche Bank AG | |
| 26.04.24 | AstraZeneca Overweight | Barclays Capital | |
| 25.04.24 | AstraZeneca Sell | UBS AG | |
| 25.04.24 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 25.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 24.04.24 | AstraZeneca Outperform | Bernstein Research | |
| 23.04.24 | AstraZeneca Overweight | JP Morgan Chase & Co. |
Aktuelle Aktienanalysen
| 21.04.26 | Ströer Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.04.26 | BASF Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 21.04.26 | Unilever Sector Perform | RBC Capital Markets | |
| 21.04.26 | TUI Overweight | JP Morgan Chase & Co. | |
| 21.04.26 | Nemetschek Overweight | JP Morgan Chase & Co. | |
| 21.04.26 | Fresenius Medical Care Equal Weight | Barclays Capital | |
| 21.04.26 | Fresenius Overweight | Barclays Capital | |
| 21.04.26 | UniCredit Overweight | JP Morgan Chase & Co. | |
| 21.04.26 | TAG Immobilien Overweight | Barclays Capital | |
| 21.04.26 | RELX Overweight | Barclays Capital | |
| 21.04.26 | Apple Overweight | JP Morgan Chase & Co. | |
| 21.04.26 | RWE Buy | UBS AG | |
| 21.04.26 | Rio Tinto Sector Perform | RBC Capital Markets | |
| 21.04.26 | Rio Tinto Hold | Jefferies & Company Inc. | |
| 21.04.26 | Bayer Overweight | JP Morgan Chase & Co. | |
| 20.04.26 | Hermès Outperform | RBC Capital Markets | |
| 20.04.26 | Alphabet A Overweight | JP Morgan Chase & Co. | |
| 20.04.26 | Ahold Delhaize Market-Perform | Bernstein Research | |
| 20.04.26 | PUMA Outperform | Bernstein Research | |
| 20.04.26 | Inditex Outperform | Bernstein Research | |
| 20.04.26 | Zalando Market-Perform | Bernstein Research | |
| 20.04.26 | RWE Market-Perform | Bernstein Research | |
| 20.04.26 | EssilorLuxottica Market-Perform | Bernstein Research | |
| 20.04.26 | UniCredit Overweight | Barclays Capital | |
| 20.04.26 | Diageo Outperform | Bernstein Research | |
| 20.04.26 | AB InBev Outperform | Bernstein Research | |
| 20.04.26 | Novo Nordisk Neutral | JP Morgan Chase & Co. | |
| 20.04.26 | Novo Nordisk Hold | Jefferies & Company Inc. | |
| 20.04.26 | GSK Underweight | JP Morgan Chase & Co. | |
| 20.04.26 | EVOTEC Outperform | RBC Capital Markets | |
| 20.04.26 | ASOS Sector Perform | RBC Capital Markets | |
| 20.04.26 | Hennes & Mauritz AB Sector Perform | RBC Capital Markets | |
| 20.04.26 | HUGO BOSS Sector Perform | RBC Capital Markets | |
| 20.04.26 | Inditex Outperform | RBC Capital Markets | |
| 20.04.26 | Zalando Outperform | RBC Capital Markets | |
| 20.04.26 | Semperit kaufen | Warburg Research | |
| 20.04.26 | Rheinmetall Outperform | Bernstein Research | |
| 20.04.26 | Lufthansa Market-Perform | Bernstein Research | |
| 20.04.26 | Fraport Outperform | Bernstein Research | |
| 20.04.26 | Linde Outperform | Bernstein Research | |
| 20.04.26 | Air Liquide Outperform | Bernstein Research | |
| 20.04.26 | BBVA Neutral | UBS AG | |
| 20.04.26 | Hermès Neutral | UBS AG | |
| 20.04.26 | easyJet Buy | UBS AG | |
| 20.04.26 | BASF Outperform | Bernstein Research | |
| 20.04.26 | Aurubis Neutral | UBS AG | |
| 20.04.26 | Bechtle Buy | UBS AG | |
| 20.04.26 | FUCHS Buy | Deutsche Bank AG | |
| 20.04.26 | ATOSS Software Buy | Deutsche Bank AG | |
| 20.04.26 | Fresenius Buy | Deutsche Bank AG |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.